HPV/Genital Warts News

First introduced in 2006, the multi-dose human papillomavirus (HPV) vaccine can prevent most cervical and anal cancers among children and young adults exposed to the virus. It can also prevent the majority of both HPV-driven oral and penile cancers.

Overall, anal cancer rates and deaths are increasing nearly 3% per year, making it one of the fastest-rising cancers.

New studies included millions of doses of Gardasil 9 vaccine, the only vaccine currently used in the United States for the prevention of HPV-related cancers.

Oral HPV infections declined by 37% among unvaccinated 18- to 59-year-old men between 2009 and 2016, according to a Sept. 10 report in the Journal of the American Medical Association.

The younger the age at vaccination, the more effective the vaccine, the findings showed.

HPV infection is common, and healthy people often clear it from the body without developing cancer. But HIV infection weakens the immune system, making it more difficult to fight off HPV.

The new study finds that rates of infection with HPV 16 or 18 -- the two strains most heavily implicated in cervical cancer -- have markedly declined between 2008 and 2014.

"Just because we detect HPV DNA in the hand doesn't necessarily mean the viral particles are viable or that there is enough to cause an infection," the study's lead author says.

Vocal cord, or glottic cancer, has been associated strongly with smoking and almost entirely seen in patients over 40 years, but today nonsmokers make up nearly half of glottic cancer patients, and it is common for them to be diagnosed under the age of

Researchers found that among the women studied, those infected with "high-risk" strains of human papillomavirus (HPV) were somewhat more likely to develop heart disease or suffer a stroke over the next several years.

HPV (human papillomavirus) vaccination has increased in recent years, rates remain well below the government's 2020 goal of 80 percent of age-eligible adolescents, according to a recent report by the President’s Cancer Panel.

About 14 million Americans become infected with HPV every year, the CDC says. About 12,000 women are diagnosed with cervical cancer and about 4,000 women die from cervical cancer caused by certain HPV viruses.

Investigators who studied nearly 200,000 young women said they found no elevated risk of premature menopause after recommended vaccinations, including for the human papillomavirus.

Nearly 66 percent of boys and girls aged 13 to 17 received the first dose in the HPV vaccine series in 2017, according to the U.S. Centers for Disease Control and Prevention researchers. And nearly 49 percent of adolescents received all the recommended doses to complete the series. The human papillomavirus (HPV) causes most cases of cervical cancer.

In the United States, HPV vaccination is recommended for girls aged 11-12. For those who did not receive the vaccine at this age, catch-up vaccination has been recommended between ages 13 and 26.

Of nearly 181,000 girls who were vaccinated, about 680 were diagnosed with an autoimmune disease between one week and two months later.

HPV is a sexually transmitted virus that can cause cervical, vulvar, vaginal, penile, anal, mouth and throat cancers. The HPV vaccine is recommended as a routine childhood vaccination.

Testing can detect HPV before it leads to cervical cancer. However, that's not the case for head and neck cancers, the researchers said.

Men infected with genital human papillomavirus (HPV) are at high risk for reinfection with the same type of HPV, researchers say.

Analysis of millions of recipients finds no link to 44 different illnesses

Vaccine provides protection, but number of boys getting shots remains low, researchers say

'Herd immunity' effect shows U.S. females now less likely to contract the cancer-causing virus

Rrates still lagging against the cancer-causing virus that's caused by sexual contact, CDC says

But vaccine should turn the tide against virus that can cause cancer, sexual health expert says

Women who've been immunized still need the screen every 3 to 5 years, cancer specialists say